Gas chromatography (GC) tests show spoilage yeasts alter flavor and raise alcohol in NoLo beer.
|Articles|September 21, 2019
- LCGC E-Books-09-02-2019
- Volume Sponsored eBook
- Issue 21
Data Integrity in Regulated Labs, Part 2
Ensuring data integrity requires the management of many moving parts as well as an understanding of regulatory terms and conditions. In this ebook, Data Integrity in Regulated Labs, Part 2, LCGC continues its series on data integrity, authored by R.D. McDowall, director of RD McDowall Ltd.
Related to this article
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) finds low glyphosate residues of the weedkiller glyphosate in coffee beans.
This week, Chromatography Online explored how the technique is advancing wastewater drug monitoring, siRNA method development, and food safety testing, with previews of RAFA 2026 and a return to HPLC fundamentals with Michael Dong.
Recent EU legislation on PFAS shifts from monitoring individual compounds toward managing them as a chemical class.
In this seventh part of " Conversations with Michael Dong," a series on fundamentals of HPLC in pharmaceutical analysis, LCGC International’s "Perspectives in HPLC" column editor explains why 2.1-mm i.d. columns are less preferred for pharmaceutical quality control.
Ultrahigh-performance liquid chromatography–quadrupole time-of-flight mass spectrometry (UHPLC–QTOF-MS) shows how soaking and cooking break down soybean fats.
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) links altered metabolism to lingering symptoms in Ebola survivors.
Nicolai Zederkopff explores chromatography’s role to help implement the maximum tolerable level (MTL) framework for food adulteration to translate analytical results into compliance decisions.
Trending on LCGC International
1
GC Reveals How Yeasts Spoil Non-alcoholic Beer
2
Conversations with Michael Dong: Why 2.1-mm i.d. Columns Are Less Preferred for Pharmaceutical Quality Control
3
Mass Spectrometry Imaging in Food: The Power and the Limits
4
AI/ML Now: Bayesian Optimization and Automation for siRNA Method Development (Part Two)
5